Clinical trial
Prospective, Multicenter, Multi-national, Single Arm Trial Evaluating the Efficacy, Safety and Long Term Functional Outcomes of Percutaneous Mechanical Aspiration Thrombectomy for Treatment of Acute Pulmonary Embolism Using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System
NCT06697314 is registered in ClinicalTrials.gov with Angiodynamics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Multicenter, Multi-national, Single Arm Trial Evaluating the Efficacy, Safety and Long Term Functional Outcomes of Percutaneous Mechanical Aspiration Thrombectomy for Treatment of Acute Pulmonary Embolism Using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System
- Lead sponsor
- Angiodynamics, Inc.
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 15, 2025
- Completion date
- June 30, 2028
- Enrollment
- 256 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute pulmonary embolism (pe), pulmonary embolism